Approximately 237,879 units of various topical medications and solutions are being recalled, including Blis-To-Sol Liquid (tolnaftate), Yager's Liniment, and Unguentine Ointment. These products were manufactured under conditions that deviated from current good manufacturing practices (CGMP), meaning their safety and quality standards cannot be guaranteed. The recall covers products distributed nationwide under several brands including Oakhurst, Larkspur, and CooperSurgical. There have been no reported incidents or injuries related to these products to date.
Failure to follow manufacturing standards can result in products that are contaminated, ineffective, or have inconsistent concentrations of active ingredients. While no injuries are reported, using medications that do not meet quality standards may fail to treat conditions properly or cause adverse skin reactions.
You have 3 options:
Distributed by Oakhurst Company.
Distributed by The Oakhurst Co.
Distributed by The Larkspur Group, Inc.
Distributed by Oakhurst Company.
Manufactured for All USA Direct, LLC.
Manufactured for CooperSurgical.
Manufactured for CooperSurgical.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.